A closer look into the GL7 antigen

Its spatio-temporally selective differential expression and localization in lymphoid cells and organs in human

Andrea Balogh, Mónika Ádori, Katalin Török, J. Matkó, Glória László

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The GL7 epitope was originally described as part of a late lymphocyte activation antigen expressed in mouse and widely used since then as a marker of germinal center. Here we report on its differential expression by rat and human immune cells and lymphoid organs. Expression pattern of the GL7 epitope in rats is similar to that described earlier in mice, namely that GL7 antigen appears only on lymphocytes after 48h activation. In humans lymphocytes, but not the differentiated cells of myeloid origin, express this epitope. The GL7 epitope is up-regulated upon in vitro activation of primary T cells, while a slightly decreased expression is found on B lymphocytes. Fluorescent immunohistochemistry shows discrete location of GL7hi cells in human tonsil. GL7 antibody intensely stains CD19+, IgD+, IgMlow B lymphocytes found at the margin of B cell follicles. The GL7 epitope is constitutively and highly raft-associated in human lymphoid cells. Strong neuraminidase- and partial papain-sensitivity of the GL7 epitope on human lymphocytes indicates a sialic acid-containing epitope linked either to one (or more) membrane protein(s) or to lipids. The lymphocyte-restricted GL7 epitope expression and the activation-dependent bi-directional change in the amount of the epitope suggest a functional role for GL7 epitope linked to carbohydrate-based immunoregulation.

Original languageEnglish
Pages (from-to)89-96
Number of pages8
JournalImmunology Letters
Volume130
Issue number1-2
DOIs
Publication statusPublished - May 2010

Fingerprint

Epitopes
Lymphocytes
B-Lymphocytes
antigen GL7
Immunoglobulin D
Germinal Center
Papain
Palatine Tonsil
Neuraminidase
N-Acetylneuraminic Acid
Myeloid Cells
Lymphocyte Activation
Membrane Proteins
Coloring Agents
Immunohistochemistry
Carbohydrates
T-Lymphocytes
Lipids
Antigens
Antibodies

Keywords

  • Carbohydrate epitope
  • GL7
  • Human lymphocytes
  • Lectins
  • Lipid rafts
  • Rat lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

A closer look into the GL7 antigen : Its spatio-temporally selective differential expression and localization in lymphoid cells and organs in human. / Balogh, Andrea; Ádori, Mónika; Török, Katalin; Matkó, J.; László, Glória.

In: Immunology Letters, Vol. 130, No. 1-2, 05.2010, p. 89-96.

Research output: Contribution to journalArticle

Balogh, Andrea ; Ádori, Mónika ; Török, Katalin ; Matkó, J. ; László, Glória. / A closer look into the GL7 antigen : Its spatio-temporally selective differential expression and localization in lymphoid cells and organs in human. In: Immunology Letters. 2010 ; Vol. 130, No. 1-2. pp. 89-96.
@article{6366fafc196b4c73875cd223071e3b4c,
title = "A closer look into the GL7 antigen: Its spatio-temporally selective differential expression and localization in lymphoid cells and organs in human",
abstract = "The GL7 epitope was originally described as part of a late lymphocyte activation antigen expressed in mouse and widely used since then as a marker of germinal center. Here we report on its differential expression by rat and human immune cells and lymphoid organs. Expression pattern of the GL7 epitope in rats is similar to that described earlier in mice, namely that GL7 antigen appears only on lymphocytes after 48h activation. In humans lymphocytes, but not the differentiated cells of myeloid origin, express this epitope. The GL7 epitope is up-regulated upon in vitro activation of primary T cells, while a slightly decreased expression is found on B lymphocytes. Fluorescent immunohistochemistry shows discrete location of GL7hi cells in human tonsil. GL7 antibody intensely stains CD19+, IgD+, IgMlow B lymphocytes found at the margin of B cell follicles. The GL7 epitope is constitutively and highly raft-associated in human lymphoid cells. Strong neuraminidase- and partial papain-sensitivity of the GL7 epitope on human lymphocytes indicates a sialic acid-containing epitope linked either to one (or more) membrane protein(s) or to lipids. The lymphocyte-restricted GL7 epitope expression and the activation-dependent bi-directional change in the amount of the epitope suggest a functional role for GL7 epitope linked to carbohydrate-based immunoregulation.",
keywords = "Carbohydrate epitope, GL7, Human lymphocytes, Lectins, Lipid rafts, Rat lymphocytes",
author = "Andrea Balogh and M{\'o}nika {\'A}dori and Katalin T{\"o}r{\"o}k and J. Matk{\'o} and Gl{\'o}ria L{\'a}szl{\'o}",
year = "2010",
month = "5",
doi = "10.1016/j.imlet.2009.12.008",
language = "English",
volume = "130",
pages = "89--96",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A closer look into the GL7 antigen

T2 - Its spatio-temporally selective differential expression and localization in lymphoid cells and organs in human

AU - Balogh, Andrea

AU - Ádori, Mónika

AU - Török, Katalin

AU - Matkó, J.

AU - László, Glória

PY - 2010/5

Y1 - 2010/5

N2 - The GL7 epitope was originally described as part of a late lymphocyte activation antigen expressed in mouse and widely used since then as a marker of germinal center. Here we report on its differential expression by rat and human immune cells and lymphoid organs. Expression pattern of the GL7 epitope in rats is similar to that described earlier in mice, namely that GL7 antigen appears only on lymphocytes after 48h activation. In humans lymphocytes, but not the differentiated cells of myeloid origin, express this epitope. The GL7 epitope is up-regulated upon in vitro activation of primary T cells, while a slightly decreased expression is found on B lymphocytes. Fluorescent immunohistochemistry shows discrete location of GL7hi cells in human tonsil. GL7 antibody intensely stains CD19+, IgD+, IgMlow B lymphocytes found at the margin of B cell follicles. The GL7 epitope is constitutively and highly raft-associated in human lymphoid cells. Strong neuraminidase- and partial papain-sensitivity of the GL7 epitope on human lymphocytes indicates a sialic acid-containing epitope linked either to one (or more) membrane protein(s) or to lipids. The lymphocyte-restricted GL7 epitope expression and the activation-dependent bi-directional change in the amount of the epitope suggest a functional role for GL7 epitope linked to carbohydrate-based immunoregulation.

AB - The GL7 epitope was originally described as part of a late lymphocyte activation antigen expressed in mouse and widely used since then as a marker of germinal center. Here we report on its differential expression by rat and human immune cells and lymphoid organs. Expression pattern of the GL7 epitope in rats is similar to that described earlier in mice, namely that GL7 antigen appears only on lymphocytes after 48h activation. In humans lymphocytes, but not the differentiated cells of myeloid origin, express this epitope. The GL7 epitope is up-regulated upon in vitro activation of primary T cells, while a slightly decreased expression is found on B lymphocytes. Fluorescent immunohistochemistry shows discrete location of GL7hi cells in human tonsil. GL7 antibody intensely stains CD19+, IgD+, IgMlow B lymphocytes found at the margin of B cell follicles. The GL7 epitope is constitutively and highly raft-associated in human lymphoid cells. Strong neuraminidase- and partial papain-sensitivity of the GL7 epitope on human lymphocytes indicates a sialic acid-containing epitope linked either to one (or more) membrane protein(s) or to lipids. The lymphocyte-restricted GL7 epitope expression and the activation-dependent bi-directional change in the amount of the epitope suggest a functional role for GL7 epitope linked to carbohydrate-based immunoregulation.

KW - Carbohydrate epitope

KW - GL7

KW - Human lymphocytes

KW - Lectins

KW - Lipid rafts

KW - Rat lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=77950947354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950947354&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2009.12.008

DO - 10.1016/j.imlet.2009.12.008

M3 - Article

VL - 130

SP - 89

EP - 96

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1-2

ER -